Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities

Go back to Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
(NASDAQ: PSNL) Delayed: 16.24 -0.09 (0.55%)
Previous Close $16.33    52 Week High
Open $16.46    52 Week Low
Day High $16.58    P/E N/A 
Day Low $16.22    EPS
Volume 345,533